- GlobeNewswire•4 days ago
Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting
SALT LAKE CITY, March 20, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that the company will present five scientific posters at the 2017 American ...
- Zacks•10 days ago
Myriad Genetics, Inc. (MYGN), a leading name in the molecular diagnostics space, recently launched the EndoPredict test in the U.S. for patients with ER+ HER2 -- early-stage breast cancer.
- GlobeNewswire•11 days ago
SALT LAKE CITY, March 13, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it has launched the EndoPredict ® test in the United States for ...
MYGN : Summary for Myriad Genetics, Inc. - Yahoo Finance
Myriad Genetics, Inc. (MYGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||19.01 x 100|
|Ask||20.25 x 200|
|Day's Range||19.07 - 19.49|
|52 Week Range||15.15 - 39.74|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.90|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|